Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-5-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
317-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9135509-Aged,
pubmed-meshheading:9135509-Humans,
pubmed-meshheading:9135509-Male,
pubmed-meshheading:9135509-Middle Aged,
pubmed-meshheading:9135509-Neoplasm Proteins,
pubmed-meshheading:9135509-Neuropeptide Y,
pubmed-meshheading:9135509-Prostatic Neoplasms,
pubmed-meshheading:9135509-Vasoactive Intestinal Peptide
|
pubmed:year |
1997
|
pubmed:articleTitle |
Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma.
|
pubmed:publicationType |
Letter
|